TECX
Tectonic Therapeutic, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.15
+2.42%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.32
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.18
- EPS estimate
- -$1.35
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2.3%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $60
- PT range
- $26 – $93
- Analysts
- 2
1 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.35 | -$1.18 | Beat 12.59% | — |
| May 7, 2026 | -$1.16 | -$1.34 | Miss -15.52% | — |
| Nov 6, 2025 | -$1.05 | -$1.02 | Beat 2.86% | — |
| Aug 7, 2025 | -$0.98 | -$1.07 | Miss -9.18% | — |
| May 8, 2025 | -$1.10 | -$0.93 | Beat 15.45% | — |
| Mar 20, 2025 | -$1.39 | -$0.84 | Beat 39.57% | — |
| Nov 7, 2024 | -$0.84 | -$1.20 | Miss -42.86% | — |
| Aug 14, 2024 | -$1.96 | -$3.81 | Miss -94.39% | — |
| May 9, 2024 | -$4.32 | -$1.80 | Beat 58.33% | — |
| Mar 14, 2024 | -$4.04 | -$2.40 | Beat 40.59% | — |
| Jun 29, 2019 | — | -$8.01 | — | — |
| Mar 30, 2019 | — | -$8.59 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026